Evidence map›Paper›PMID 40038175›Full record

ArticleMedical oncology (Northwood, London, England)2025

Effects of royal jelly on ovary cancer cells proliferation and apoptosis.

Ender Deniz Asmaz, Sabire Güler, Berrin Zık

Abstract read
In one paragraph

Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ender Deniz AsmazDepartment of Histology and Embryology, Faculty of Medicine Ankara Medipol University Ankara, Ankara, Turkey.ORCID http://orcid.org/0000-0001-6468-8535
Sabire GülerDepartment of Histology Embryology, Faculty of Veterinary Medicine, Uludag University, Bursa, Turkey.ORCID http://orcid.org/0000-0002-7367-6859
Berrin ZıkDepartment of Histology Embryology, Faculty of Veterinary Medicine, Uludag University, Bursa, Turkey. bzik@uludag.edu.tr.ORCID http://orcid.org/0000-0002-1053-6250

Funding

Bursa Uludag University Scientific Research Committee (BAP) TDK-2021-388
6 · The paper itself

Abstract

The aim of the present study is to investigate the proliferative or apoptotic effects of different doses and durations of Royal jelly (RJ) on serous type epithelial ovarian cancer, which is the most common epithelial ovarian cancer. For this purpose, cells of the Skov-3 human ovarian adenocarcinoma cell line were grown in McCoy medium and seeded in 6-well plates. RJ was prepared as a stock solution (1000 mg RJ/10 ml dH

Indexed as

ApoptosisCell ProliferationFatty AcidsOvarian NeoplasmsCarcinoma, Ovarian EpithelialCell Line, TumorCell SurvivalFemaleHumansRoyal JellyFatty AcidsRoyal JellyApoptosisOvarian cancerProliferationRoyal jelly

Identifiers

PMID40038175
PMCPMC11880105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.